Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-β1-induced renal injury
Open Access
- 1 September 2009
- journal article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 297 (3), F729-F739
- https://doi.org/10.1152/ajprenal.00086.2009
Abstract
Excessive accumulation of extracellular matrix (ECM) in the kidneys and epithelial-to-mesenchymal transition (EMT) of renal tubular epithelial cells contributes to the renal fibrosis that is associated with diabetic nephropathy. Histone deacetylase (HDAC) determines the acetylation status of histones and thereby controls the regulation of gene expression. This study examined the effect of HDAC inhibition on renal fibrosis induced by diabetes or transforming growth factor (TGF)-β1 and determined the role of reactive oxygen species (ROS) as mediators of HDAC activation. In streptozotocin (STZ)-induced diabetic kidneys and TGF-β1-treated normal rat kidney tubular epithelial cells (NRK52-E), we found that trichostatin A, a nonselective HDAC inhibitor, decreased mRNA and protein expressions of ECM components and prevented EMT. Valproic acid and class I-selective HDAC inhibitor SK-7041 also showed similar effects in NRK52-E cells. Among the six HDACs tested (HDAC-1 through -5 and HDAC-8), HDAC-2 activity significantly increased in the kidneys of STZ-induced diabetic rats and db/db mice and TGF-β1-treated NRK52-E cells. Levels of mRNA expression of fibronectin and α-smooth muscle actin were decreased, whereas E-cadherin mRNA was increased when HDAC-2 was knocked down using RNA interference in NRK52-E cells. Interestingly, hydrogen peroxide increased HDAC-2 activity, and the treatment with an antioxidant, N-acetylcystein, almost completely reduced TGF-β1-induced activation of HDAC-2. These findings suggest that HDAC-2 plays an important role in the development of ECM accumulation and EMT in diabetic kidney and that ROS mediate TGF-β1-induced activation of HDAC-2.Keywords
This publication has 43 references indexed in Scilit:
- Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activityHepatology, 2008
- Protein kinase CK2 is a key activator of histone deacetylase in hypoxia‐associated tumorsInternational Journal of Cancer, 2007
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- High Levels of Oxidative Stress Globally Inhibit Gene Transcription and Histone AcetylationDNA and Cell Biology, 2006
- Hypoxia inhibits adipocyte differentiation in a HDAC-independent mannerBiochemical and Biophysical Research Communications, 2005
- Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary DiseaseThe New England Journal of Medicine, 2005
- Molecular Evolution of the Histone Deacetylase Family: Functional Implications of Phylogenetic AnalysisJournal of Molecular Biology, 2004
- Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular DifferentiationCancer Research, 2004
- Synthesis and Biological Evaluation of 3-(4-Substituted-phenyl)-N-hydroxy-2-propenamides, a New Class of Histone Deacetylase InhibitorsJournal of Medicinal Chemistry, 2003
- The Transcriptional Repressor Sp3 Is Associated with CK2-phosphorylated Histone Deacetylase 2Online Journal of Public Health Informatics, 2002